Search research articles
Contact Us
Filters
Showing results (1-10 of 304) with videos related to
Page
of 31
Sort By:
Mbio
|
February 11, 2025
mGem: A quarter century with the Pirofski-Casadevall damage response framework-a dynamic construct for understanding microbial pathogenesis
Joshua D Nosanchuk
Recent Patents on Anti-Infective Drug Discovery
|
January 29, 2008
Current status and future of antifungal therapy for systemic mycoses
Joshua D Nosanchuk
Virulence
|
August 28, 2013
The interdependence of antibody C and V regions on specificity and affinity: significant implications for the engineering of therapeutic antibodies
Joshua D Nosanchuk
Virulence
|
June 10, 2015
Virulence profile: Joshua D Nosanchuk
Joshua D Nosanchuk
Frontiers in Microbiology
|
January 26, 2012
Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens
Joshua D Nosanchuk, Ekaterina Dadachova
Cellular Microbiology
|
April 5, 2003
The contribution of melanin to microbial pathogenesis
Joshua D Nosanchuk, Arturo Casadevall
Microbes and Infection
|
August 2, 2008
Histoplasma capsulatum at the host-pathogen interface
Joshua D Nosanchuk, Attila Gacser
Antimicrobial Agents and Chemotherapy
|
October 27, 2006
Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds
Joshua D Nosanchuk, Arturo Casadevall
Microbiology (Reading, England)
|
July 12, 2003
Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa
Joshua D Nosanchuk, Arturo Casadevall
Cell Cycle (Georgetown, Tex.)
|
September 8, 2011
Lipid droplet formation protects against gluco/lipotoxicity in Candida parapsilosis: an essential role of fatty acid desaturase Ole1
Long Nam Nguyen, Joshua D Nosanchuk
Page
of 31
Search research articles
Search
Showing results (1-10 of 304) with videos related to
Sort By:
Page
of 31
Mbio
|
February 11, 2025
mGem: A quarter century with the Pirofski-Casadevall damage response framework-a dynamic construct for understanding microbial pathogenesis
Joshua D Nosanchuk
Recent Patents on Anti-Infective Drug Discovery
|
January 29, 2008
Current status and future of antifungal therapy for systemic mycoses
Joshua D Nosanchuk
Virulence
|
August 28, 2013
The interdependence of antibody C and V regions on specificity and affinity: significant implications for the engineering of therapeutic antibodies
Joshua D Nosanchuk
Virulence
|
June 10, 2015
Virulence profile: Joshua D Nosanchuk
Joshua D Nosanchuk
Frontiers in Microbiology
|
January 26, 2012
Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens
Joshua D Nosanchuk, Ekaterina Dadachova
Cellular Microbiology
|
April 5, 2003
The contribution of melanin to microbial pathogenesis
Joshua D Nosanchuk, Arturo Casadevall
Microbes and Infection
|
August 2, 2008
Histoplasma capsulatum at the host-pathogen interface
Joshua D Nosanchuk, Attila Gacser
Antimicrobial Agents and Chemotherapy
|
October 27, 2006
Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds
Joshua D Nosanchuk, Arturo Casadevall
Microbiology (Reading, England)
|
July 12, 2003
Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa
Joshua D Nosanchuk, Arturo Casadevall
Cell Cycle (Georgetown, Tex.)
|
September 8, 2011
Lipid droplet formation protects against gluco/lipotoxicity in Candida parapsilosis: an essential role of fatty acid desaturase Ole1
Long Nam Nguyen, Joshua D Nosanchuk
Page
of 31